Your session is about to expire
← Back to Search
Post-SABR Biopsy for Lung Cancer
Study Summary
This trial will compare how well two different types of biopsies, taken before and after a treatment for lung cancer, can identify which tumors the treatment has worked on.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am older than 18 years.I am post-menopausal or not currently pregnant.My organs and bone marrow are functioning well.My primary tumor cannot be repeatedly biopsied.I am not currently taking any experimental drugs or chemotherapy.I haven't used steroids 14 days before or during my radiation treatment.My lung cancer was confirmed through initial biopsies.My lung cancer is in the early stage (Stage I).My tumor can be treated with a specific type of targeted radiation therapy.I am willing and able to follow the study's treatment plan and attend all visits.I am not pregnant from the start to the end of the treatment.I have enough biopsy samples for further testing.I have not received any immunotherapy.I have had radiation therapy in the chest area before.My tumor can be easily reached for a biopsy.
- Group 1: Stage I NSCLC with SABR Therapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still opportunities to join this experiment?
"According to the data hosted on clinicaltrials.gov, this experiment is actively seeking participants. It was initially posted in October 2018 and has been modifyied most recently in September 2022."
May I be part of this research experiment?
"This medical study seeks 10 volunteers between 18-100 years of age who possess a malignancy in their lungs. The applicants must be willing and capable to comply with all aspects of the clinical trial including subsequent treatments and evaluations, have an accessible tumor for biopsy, and demonstrate that their tumour is suitable for SABR therapy as declared by a radiation oncologist."
Is there an age restriction for enrolment into this experiment?
"According to the specifications of this clinical trial, only individuals aged 18-100 can join. This is distinct from 42 studies that accept patients younger than 18 and 1904 trials open for enrolment by those over 65 years old."
What is the total enrolment number for this research endeavor?
"Affirmative. Clinicaltrials.gov conveys that this medical investigation, which was initially uploaded on October 16th 2018, is actively recruiting patients. Approximately 10 volunteers need to be recruited from a single healthcare facility."
Share this study with friends
Copy Link
Messenger